The Food and Drug Administration has ended the shortage of Ozempic and Wegovy, a step that could mark the end of a growing market for affordable weight-loss drugs. However, many patients express frustration over the high cost and insurance barriers associated with obtaining these medications.
Source: https://www.washingtonpost.com/business/2025/02/21/fda-ends-shortage-ozempic-wegovy